BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/8/2021 9:54:09 AM | Browse: 655 | Download: 1760
 |
Received |
|
2020-10-18 03:09 |
|
Peer-Review Started |
|
2020-10-18 03:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-20 06:28 |
|
Revised |
|
2020-11-20 12:57 |
|
Second Decision |
|
2020-11-30 09:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-12-06 01:20 |
|
Articles in Press |
|
2020-12-06 01:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-12-11 21:52 |
|
Typeset the Manuscript |
|
2020-12-28 00:59 |
|
Publish the Manuscript Online |
|
2021-01-08 09:54 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Gut microbiota and inflammatory bowel disease: The current status and perspectives
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lie Zheng and Xin-Li Wen |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shaanxi Province Natural Science Basic Research Program-general Project |
2019JM-580 |
| Project of Shaanxi Administration of Traditional Chinese Medicine |
2019-ZZ-JC0010 |
| Shaanxi Provincial Hospital of Traditional Chinese Medicine |
2018-04 |
|
| Corresponding Author |
Xin-Li Wen, N/A, Director, Director, Professor, Department of Gastroenterology, Shaanxi Provincial Hospital of Traditional Chinese Medicine, No. 4 Xihuamen, Xi’an 730000, Shaanxi Province, China. xinliwen696@126.com |
| Key Words |
Inflammatory bowel disease; Microbiome; Inflammation; Genetics; Antibiotics; Probiotics |
| Core Tip |
Inflammatory bowel disease (IBD) is a chronic immune-mediated disease, affecting the gastrointestinal tract. Researchers have proved that some factors can provide support to the curative effect of the microbiome in patients with IBD, including the identification of mutations in genes involved in microbiome-immune interactions and microbiota-modulating risk factors such as antibiotic use, cigarette smoking, levels of sanitation, and diet involved in pathogenesis of the disease. As a result, there has been increasing interest in the application of probiotics, prebiotics, antibiotics, fecal microbiota transplantation, and gene manipulation in treating IBD because of the possible curative effect of microbiome-modulating interventions. |
| Publish Date |
2021-01-08 09:54 |
| Citation |
Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i2/321.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i2.321 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
